Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy
Innovative Research in Applied, Biological and Chemical Sciences · 2025
DOI: 10.62497/irabcs.141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovative Research in Applied, Biological and Chemical Sciences, 2025. Verfasst von Sehrish Jabeen und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Type 2 diabetes mellitus (T2DM) is a growing public health concern worldwide. While metformin is the first-line therapy, many patients require additional oral antidiabetic drugs (OADs) to achieve glycemic targets.
Objective
To determine which is better at controlling blood sugar and lowering the risk of heart disease in people with type 2 diabetes: metformin monotherapy or combination treatment. Materials and Methods: The descriptive, cross-sectional research was conducted at the Department of Endocrinology at Jinnah Hospital in Lahore between February 2023 and January 2024. A total of 132 T2DM patients were enrolled using convenience sampling and divided into two groups: Group A (metformin only; n=62) and Group B (metformin plus OADs; n=70). Fasting blood glucose, HbA1c, blood pressure, and lipid profile were assessed. Independent samples t-tests were used to compare means between groups, with p
Zitieren
APA
Jabeen, S., Anam, Abass, F., Aisha, S., & Khalid, S. (2025). Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy. Innovative Research in Applied, Biological and Chemical Sciences. https://doi.org/10.62497/irabcs.141
Vancouver
Jabeen S, Anam, Abass F, Aisha S, Khalid S. Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy. Innovative Research in Applied, Biological and Chemical Sciences. 2025. doi:10.62497/irabcs.141
BibTeX
@article{Jabeen2025,
author = {Jabeen, Sehrish and Anam and Abass, Fatima and Aisha, Syeda and Khalid, Saba},
title = {Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy},
journal = {Innovative Research in Applied, Biological and Chemical Sciences},
year = {2025},
doi = {10.62497/irabcs.141}
}
EUVIMED